Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 44Neoplasm Metastasis 19Liver Neoplasms 18Colorectal Neoplasms 15Cholangiocarcinoma 11Pancreatic Neoplasms 9Lung Neoplasms 9Colonic Neoplasms 9Breast Neoplasms 8Carcinoma, Renal Cell 7Carcinoma, Non-Small-Cell Lung 7Barrett Esophagus 7Thyroid Nodule 6Recurrence 6Rectal Neoplasms 6Thyroid Neoplasms 5Pain 4Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Thyroid Cancer, Papillary 3Prostatic Neoplasms 3Leiomyoma 3Biliary Tract Neoplasms 3Bile Duct Neoplasms 3Agnosia 3Thyroid Diseases 2Hyperaldosteronism 2Hepatitis B 2Gallbladder Neoplasms 2

Interventions

regorafenib 2Radiofrequency Ablation 1Nivolumab 1Irinotecan 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Cancer Liver Metastases × Radiofrequency Ablation × Clear all
NCT05485909 2022-08-03

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

Sun Yat-sen University

Phase 2 Unknown
32 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡